December 12, 2017

EU drug agency to Amsterdam, banking to Paris

20 November 2017, Brussels: Amsterdam and Paris won the opportunity to  host the two prominent EU agencies that must depart London due to Brexit. The decision was taken at a ministerial meeting in Brussels.

The European Medicines Authority (EMA), a key player in the continent’s healthcare industry, will go to Amsterdam prefered in a tough rivalry with Milan, and the European Banking Authority (EBA) will go to Paris, winner over Dublin.

The outcome was welcomed by European pharmaceuticals bodies. The EMA had warned that many of its staff might leave, possibly disrupting healthcare in Europe, if governments had chosen a less attractive host city, notably in the ex-communist East.

The European Commission welcomed today’s agreement at the General Affairs Council (Article 50 format) to move the European Medicines Agency (EMA) and the European Banking Authority (EBA) to Amsterdam and Paris, respectively. Both Agencies are currently located in London.

The relocation of these two Agencies is a direct consequence – and the first visible result – of the United Kingdom’s decision to leave the European Union, as notified to the European Council on 29 March 2017.

The EMA and the EBA are two key regulatory Agencies for the EU’s Single Market, and are essential for the authorisation of medicines and for bank regulation. They must continue to function smoothly and without disruption beyond March 2019, the statement said.

For further information: 


Paris – Picture by Zinneke, Wikipedia free licence

Comments are closed.